Changchun GeneScience Pharmaceutical Co., Ltd.

Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Renal & urogenital · Respiratory · Women's health

Changchun GeneScience Pharmaceutical Co., Ltd. is a clinical trial sponsor. It has 49 active clinical trials with 6,369 planned participants, across 15 therapeutic areas. Since 2021 it has completed 27 trials and stopped 4 early.

Trial track record · since 2021

49Active trials6,369 planned participants
27Completed0 with results posted
4Stopped early13% of finished trials

Pipeline · 49 active trials

StageTrialStatus

Questions about Changchun GeneScience Pharmaceutical Co., Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-05.

Approve Suite is not affiliated with Changchun GeneScience Pharmaceutical Co., Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.